Hims & Hers is a fantastic value despite its high on-the-surface P/E ratio and valuation metrics. Click here to read why HIMS ...

We recently compiled a list of the 10 Best Hair Care Stocks To Buy Now. In this article, we are going to take a look at where ...

U.S. telehealth company Hims & Hers Health on Wednesday said it will sell compounded versions of Novo Nordisk's popular ...

Hims & Hers Health (HIMS -3.66%) has built its brand up in recent years by focusing on offering its customers products ...

The biggest news was Hims & Hers issuing 976,341 shares of common stock to acquire Nivagen Pharmaceuticals, which does ...

In the latest market close, Hims & Hers Health, Inc. (HIMS) reached $16.44, with a +0.86% movement compared to the previous day. The stock exceeded the S&P 500, which registered a gain of 0.28% for ...

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

Hims & Hers Health will offer compounded GLP-1 weight-loss medications for as low as $99 per month to eligible U.S. military ...

Hims & Hers, the telehealth company, saw its stock price range from under $6 to over $25 during the last 52 weeks. Click here ...

Advertiser Disclosure. Hims is an online telehealth platform for men that provides care for mental health, sexual health, hair loss, skincare and more. Outside of offering telehealth appointments with ...

Check the time stamp on this data. Updated AI-Generated Signals for Hims & Hers Health Inc. Class A (HIMS) available here: ...

Adam Spatacco has positions in Eli Lilly and Novo Nordisk. The Motley Fool has positions in and recommends Pfizer, Target, and Teladoc Health. The Motley Fool recommends Johnson & Johnson, Moderna, ...